Literature DB >> 23529497

Periprocedural management of antithrombotic therapy and use of bridging anticoagulation.

Andrew Nicolaides, Russell D Hull, Jawed Fareed.   

Abstract

Mesh：

Substances：

Year:  2013        PMID： 23529497     DOI： 10.1177/1076029612474840u

Source DB:  PubMed          Journal:  Clin Appl Thromb Hemost        ISSN： 1076-0296            Impact factor:   2.389


× No keyword cloud information.
  1 in total

1.  Improved Benefit Risk Profile of Rivaroxaban in a Subpopulation of the MAGELLAN Study.

Authors:  Alex C Spyropoulos; Concetta Lipardi; Jianfeng Xu; Wentao Lu; Eunyoung Suh; Zhong Yuan; Bennett Levitan; Chiara Sugarmann; Yoriko De Sanctis; Theodore E Spiro; Elliot S Barnathan; Gary E Raskob
Journal:  Clin Appl Thromb Hemost       Date:  2019 Jan-Dec       Impact factor: 2.389
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.